Cargando…

B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases

BACKGROUND: B-cell prolymphocytic leukemia (B-PLL) is a rare mature B-cell tumor with an aggressive clinical course and poor prognosis. It is characterized by prominent splenomegaly and prolymphocytes exceeding 55% of the lymphoid cells in the blood. Purine analog-based chemo-immunotherapy is the fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Anna, Guo, Wei, Damiani, Daniela, Sumbly, Vikram, Goyal, Gaurav, Du, Zhonghua, Bai, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425637/ https://www.ncbi.nlm.nih.gov/pubmed/37588745 http://dx.doi.org/10.21037/tcr-23-828

Ejemplares similares

Painful, plantar nodules in cutaneous macroglobulinosis: Successful treatment with rituximab and bendamustine
por: D'Acunto, Carmine, et al.
Publicado: (2020)

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)
por: Stilgenbauer, Stephan, et al.
Publicado: (2020)

T-cell Prolymphocytic Leukemia, Cerebriform Variant
por: Carvalho, José, et al.
Publicado: (2021)

Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
por: Xing, Lijie, et al.
Publicado: (2021)

B‐prolymphocytic leukemia (B‐PLL) with genetic aberrations involving MYC and TP53
por: Tamber, Gurdip Singh, et al.
Publicado: (2021)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
por: Rai, Shinya, et al.
Publicado: (2018)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
por: Bega, Giulia, et al.
Publicado: (2021)

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
por: Sriwijitalai, Won, et al.
Publicado: (2019)

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Coutre, Steven E., et al.
Publicado: (2018)

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
por: Visentin, Andrea, et al.
Publicado: (2017)

T-cell Prolymphocytic Leukemia Presenting as Red Eye
por: Alwadani, Fahad
Publicado: (2011)

Advances in the understanding and management of T-cell prolymphocytic leukemia
por: Laribi, Kamel, et al.
Publicado: (2017)

An illustrative case of B-cell prolymphocytic leukemia
por: Jain, Ankur, et al.
Publicado: (2020)

Bilateral tonsillar infiltration of T‐cell prolymphocytic leukemia
por: Bertaggia, Ilaria, et al.
Publicado: (2019)

Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
por: Kornauth, Christoph, et al.
Publicado: (2021)

Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia
por: Varadarajan, Indumathy, et al.
Publicado: (2022)

De-Novo B-Cell Prolymphocytic Leukemia
por: Menakuru, Sasmith R., et al.
Publicado: (2023)

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
por: Gutierrez, Marc, et al.
Publicado: (2023)

Bendamustine/dexamethasone/rituximab: Cytomegalovirus reactivation : case report
Publicado: (2021)

Bendamustine/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Bendamustine/rituximab: Neutropenia, fever and inflammation: case report
Publicado: (2022)

Bullous leukemia cutis in a patient with T-cell prolymphocytic leukemia
por: Siu, Sarah Y., et al.
Publicado: (2016)

Two rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine
por: Panitz, Nydia, et al.
Publicado: (2021)

T-cell Prolymphocytic Leukemia with Cutaneous Involvement as the Presenting Feature
por: Ashturkar, Amrut V, et al.
Publicado: (2012)

T‐cell prolymphocytic leukemia and tuberculosis: a puzzling association
por: Cervera, Pascale, et al.
Publicado: (2017)

SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
por: Johansson, Patricia, et al.
Publicado: (2018)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
por: Hampel, Paul J., et al.
Publicado: (2021)

T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
por: Colon Ramos, Ana, et al.
Publicado: (2021)

Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormality
por: Wafa, Abdulsamad, et al.
Publicado: (2014)

Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases
por: Tsutsumi, Yutaka, et al.
Publicado: (2021)

Small cell variant of T-cell prolymphocytic leukemia with atypical presentation
por: Park, Joowon
Publicado: (2018)

Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia
por: Zhao, Yantian, et al.
Publicado: (2019)

Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia
por: Tian, Shulan, et al.
Publicado: (2021)

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Braun, Till, et al.
Publicado: (2021)

Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
por: Geres, Hana, et al.
Publicado: (2023)

An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia
por: Bell, Stephen, et al.
Publicado: (2021)

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
por: Michallet, Anne-Sophie, et al.
Publicado: (2018)

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
por: Eren, Rafet, et al.
Publicado: (2018)

Isolated intracardiac recurrence of diffuse large B-cell lymphoma successfully treated with rituximab and bendamustine chemotherapy regimen
por: Chang, CH, et al.
Publicado: (2020)

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
por: Monteiro, Rowan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvgo2ianjjnej6j17ejd5b4m1d